HSD11B1 and Hyperglycemia: Transgenic mice overexpressing HSD11B1 develop visceral obesity and exhibited insulin-resistant diabetes and dyslipidemia [10], while HSD11B1-knockout mice are protected from the adverse metabolic complications of obesity and high fat diet-induced hyperglycemia [11].